Network Version
Product Name: | PF-3845 | |
---|---|---|
CAS No.: | 1196109-52-0 | |
Cat. No.: | HY-14380 | |
MWt: | 456.46 | |
Formula: | C24H23F3N4O2 | |
Purity : | >98% | |
Solubility: | DMSO : ≥ 100 mg/mL (219.08 mM) | |
Mechanisms: | Target: Cancer Inflammation/Immunology | |
Biological Activity: | ||
PF-3845 is a potent, selective, irreversible and orally active inhibitor of fatty acid amide hydrolase (FAAH), with a Ki of 0.23 µM. PF-3845 is a covalent inhibitor that carbamylates FAAH's serine nucleophile. PF-3845 can reduce pain sensation, inflammation, and anxiety/depression without substantial effects on motility or cognition[1][3].
IC50 & Target: Ki: 0.23 µM (FAAH)[1]
In Vitro: PF-3845 (0.5 nM-10 μM; 40 min) inhibits human FAAH-1 (IC50=18 nM) in a concentration-dependent manner, and shows negligible activity against FAAH-2 (IC50>10 μM) in COS-7 cells[1]. PF-3845 (0.1-1000 μM; 48 h) significantly decreases the Colo-205 cell viability[2]. In Vivo: PF-3845 (1-30 mg/kg; p.o.) produces cannabinoid receptor-dependent reductions in inflammatory pain in rat[1]. PF-3845 (10 mg/kg; a single i.p.) selectively inhibits FAAH in mice for up to 24 hours[1]. PF-3845 (10 mg/kg; a single i.p.) causes a dramatic and sustained elevation in Anandamide (AEA) in mice[1]. |
1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA
Tel: 609-228-6898 Fax: 609-228-5909 Email: [email protected] Web:www.medchemexpress.com
Keywords: buy PF-3845 | PF-3845 Supplier | purchase PF-3845 | PF-3845 cost | PF-3845 manufacturer | order PF-3845 | PF-3845 distributor | PF-3845 structure buy 1196109-52-0 | 1196109-52-0 Supplier | purchase 1196109-52-0 | 1196109-52-0 cost | 1196109-52-0 manufacturer | order 1196109-52-0 | 1196109-52-0 distributor | 1196109-52-0 structure